CVS was picked by the Department of Health and Human Services to give free doses of an antibody drug to eligible coronavirus patients either in their home or long-term care facilities.
Under the pilot program, Coram, a specialty pharmacy and infusion care business under CVS Health, will be administering 1,000 doses of bamlanivimab to patients in seven cities beginning Dec.
3.Bamlanivimab, an investigational monoclonal antibody treatment produced by Eli Lilly, was granted emergency approval for use in patients with mild to moderate coronavirus by the FDA in early November.
The company recommends that the treatment be given to patients as soon as possible after a positive diagnosis and within about 10 days of symptoms.It is not approved for.